| |
| |
|
| Insider
Information: |
Ray Russell T |
| Relationship: |
Director |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
3,074,363 |
|
|
Indirect Shares
|
10,000 |
|
|
| Direct
Value |
$65,126,039 |
|
|
|
Indirect Value
|
$150,000 |
|
|
| Total
Shares |
3,084,363 |
|
|
| Total
Value |
$65,276,039 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -3.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
CombiMatrix Corp |
CBMX |
10% Owner |
2011-04-07 |
1,595,896 |
|
0 |
Premium* |
|
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
1,454,058 |
2013-11-13 |
0 |
Premium* |
|
|
Merrimack Pharmaceuticals Inc |
MACK |
Director |
2021-12-31 |
0 |
2015-01-01 |
10,000 |
Premium* |
|
|
180 Life Sciences Corp |
ATNF |
Director |
2023-09-04 |
24,409 |
2022-01-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATNF |
180 Life Sciences Corp |
Director |
– • – |
2023-09-04 |
4 |
A |
$1.36 |
$29,179 |
D/D |
21,455 |
24,409 |
0 |
- |
|
| ATNF |
180 Life Sciences Corp |
Director |
– • – |
2022-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
30,702 |
59,068 |
0 |
- |
|
| ATNF |
180 Life Sciences Corp |
Director |
– • – |
2022-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
13,068 |
28,366 |
0 |
- |
|
| ATNF |
180 Life Sciences Corp |
Director |
– • – |
2022-05-19 |
4/A |
A |
$1.36 |
$14,375 |
D/D |
10,570 |
15,298 |
0 |
- |
|
| ATNF |
180 Life Sciences Corp |
Director |
– • – |
2022-05-19 |
4 |
A |
$1.36 |
$14,375 |
D/D |
10,570 |
10,570 |
0 |
- |
|
| ATNF |
180 Life Sciences Corp |
Director |
– • – |
2022-01-14 |
4 |
A |
$3.04 |
$14,373 |
D/D |
4,728 |
4,728 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2021-12-31 |
4 |
S |
$3.84 |
$3,840 |
D/D |
(1,000) |
0 |
0 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2015-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,000 |
|
- |
|
| TNDM |
Tandem Diabetes Care Inc |
Previously a 10% Owner |
– – • |
2013-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,454,058 |
1,454,058 |
0 |
- |
|
| TNDM |
Tandem Diabetes Care Inc |
10% Owner |
– – • |
2013-11-13 |
4 |
B |
$15.00 |
$3,000,000 |
D/D |
200,000 |
200,000 |
2.45 |
- |
|
| CBMX |
CombiMatrix Corp |
10% Owner |
– – • |
2011-04-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,595,896 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
